Neo/Adjuvant Therapy in Upper Tract Urothelial Carcinoma{A figure is presented}

European Urology, Supplements

Volumn 6, Issue 8, 2007, Pages 549-554

  Türkeri, Levent N ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adjuvant; Neoadjuvant; Upper tract; Urothelial neoplasms

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; NEPHROURETERECTOMY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

EID: 33846849253     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2007.01.009     Document Type: Article

References (33)

1. Oosterlinck W., Solsona E., van der Meijden A.P., et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46 (2004) 147-154
2. Racioppi M., D'Addessi A., Alcini A., et al. Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumours. Br J Urol 80 (1997) 707-711
3. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52 (1998) 594-601
4. Batata M.A., Whitmore W.F., Hilaris B.S., et al. Primary carcinoma of the ureter: a prognostic study. Cancer 35 (1975) 1626-1632
5. Reitelman C., Sawczuk I.S., Olsson C.A., et al. Prognostic variables in patients with transitional cell carcinoma of the renal pelvis and proximal ureter. J Urol 138 (1987) 1144-1145
6. Heney N.M., Nocks B.N., Daly J.J., et al. Prognostic factors in carcinoma of the ureter. J Urol 125 (1981) 632-636
7. Guinan P., Vogelzang N.J., Randazzo R., et al. Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-1985. Cancer Incidence and End Results Committee. Urology 40 (1992) 393-399
8. Czito B., Zietman A., Kaufman D., et al. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172 (2004) 1271-1275
9. Cozad S.C., Smalley S.R., Austenfeld M., et al. Adjuvant radiotherapy in high stage transitional cell carcinoma of the renal pelvis and ureter. Int J Radiat Oncol Biol Phys 24 (1992) 743-745
10. Ozsahin M., Zouhair A., Villa S., et al. Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer 35 (1999) 738-743
11. Hall M.C., Womack J.S., Roehrborn C.G., et al. Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy. J Urol 160 (1998) 703-706
12. Brookland R.K., and Richter M.P. The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter. J Urol 133 (1985) 952-955
13. Maulard-Durdux C., Dufour B., Hennequin C., et al. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?. J Urol 155 (1996) 115-117
14. Catton C.N., Warde P., Gospodarowicz M.K., et al. transitional cell carcinoma of the renal pelvis and ureter: outcome and patterns of relapse in patients treated with postoperative radiation. Urol Oncol 2 (1996) 171-175
15. Akdogan B., Dogan H.S., Eskicorapci S.Y., et al. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol 176 (2006) 48-52
16. Kwak C., Lee S.E., Jeong I.G., et al. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 68 (2006) 53-57
17. Morioka M., Jo Y., Furukawa Y., et al. Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract. Int J Urol 8 (2001) 366-373
18. Mufti G.R., Gove J.R., Badenoch D.F., et al. Transitional cell carcinoma of the renal pelvis and ureter. Br J Urol 63 (1989) 135-140
19. Masuda M., Takano Y., Iki M., et al. Cyclin-dependent kinase inhibitor p27(Kip1) expression in transitional cell carcinoma of renal pelvis and ureter. Cancer Lett 150 (2000) 183-189
20. Masuda M., Takano Y., Iki M., et al. Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter. J Urol 161 (1999) 805-808 discussion 808-9
21. Masuda M., Takano Y., Iki M., et al. Apoptosis in transitional cell carcinoma of the renal pelvis and ureter: association with proliferative activity, bcl-2 expression and prognosis. J Urol 158 (1997) 750-753
22. Masuda M., Iki M., Takano Y., et al. Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter. J Urol 155 (1996) 1877-1880 discussion 1880-1
23. Rey A., Lara P.C., Redondo E., et al. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival. Cancer 79 (1997) 2178-2185
24. Corrado F., Ferri C., Mannini D., et al. Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis. J Urol 145 (1991) 1159-1163
25. Bamias A., Deliveliotis C., Fountzilas G., et al. Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol 22 (2004) 2150-2154
26. Lee S.H., Lin J.S., Tzai T.S., et al. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract. Eur Urol 29 (1996) 266-270 discussion 271
27. Davis B.W., Hough A.J., and Gardner W.A. Renal pelvic carcinoma: morphological correlates of metastatic behavior. J Urol 137 (1987) 857-861
28. Das A.K., Carson C.C., Bolick D., et al. Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. Cancer 66 (1990) 1919-1923
29. Kirkali Z., and Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47 (2003) 155-169
30. Zincke H., and Neves R.J. Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract. Urol Clin North Am 11 (1984) 717-724
31. Elliott D.S., Blute M.L., Patterson D.E., et al. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology 47 (1996) 819-825
32. Bamias A., Moulopoulos L.A., Koutras A., et al. The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A phase II study of the Hellenic Cooperative Oncology Group. Cancer 106 (2006) 297-303
33. Igawa M., Urakami S., Shiina H., et al. Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract. Urol Int 55 (1995) 74-77